Ticker

$PFE

Unknown company

Last price
$26.65
30-day change
+7.76%
AI Brief · $PFE· powered by Claude

Recent Trump mentions

  • News15d agonegative

    Half of Kennedy's Appointees to Panel Can Keep Drug Stocks A federal health panel that helps dictate which medical services insurers must cover now includes members with money riding on those decisions. Four of the eight people named in September by Health Secretary Robert F. Kennedy Jr. to the US Preventive Services… The members' holdings include shares in Eli Lilly, Johnson & Johnson, Merck, Pfizer, Novo Nordisk, CVS Health, and Cigna. The task force evaluates evidence for services including colonoscopies, d… [+371 chars]

    Source ↗
  • News10/19/2026negative

    EXCLUSIVE: Pfizer Executive’s Role In FDA Commissioner’s Rise Stirs Concerns HHS officials are grateful Scott Gottlieb is boosting Heidi Overton, further enmeshing the drug regulator with Big Pharma. Scott Gottlieb, the Food and Drug Administration commissioner turned Pfizer director and prominent critic of Robert Kennedy Jr., has been a key ally of incoming FDA Commissioner Heidi Overton, accord… [+5812 chars]

    Source ↗
  • News9/15/2026neutral

    Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat Pfizer Inc. (NYSE:PFE) and Valneva SE (NASDAQ:VALN) reported on August 14 that the European Medicines Agency has validated the Marketing Authorization Applic... Pfizer Inc. (NYSE:PFE) and Valneva SE (NASDAQ:VALN) reported on August 14 that the European Medicines Agency has validated the Marketing Authorization Application for PF-07307405, the companies' expe… [+5165 chars]

    Source ↗
  • News9/2/2026positive

    Pfizer Shares Hit New 52-Week High As Drug Pricing Deal, Earnings Beat And Settlement Lift Stock Further Pfizer's stock rises to a 52-week high following a drug pricing deal with the Trump administration, strong earnings, and a legal settlement resolution, marking a significant recovery for the company. NEW YORK — Shares of Pfizer Inc. climbed further Wednesday morning, trading at $29.09, up 54 cents, or 1.89%, as of 10:02 a.m. ET, matching a fresh 52-week high the pharmaceutical giant first touched… [+6275 chars]

    Source ↗
  • News8/26/2026neutral

    Pfizer vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward? Pfizer Inc. (NYSE:PFE) and Abbott Laboratories (NYSE:ABT) offer investors two very different dividend stories. Pfizer (NYSE:PFE) is working to rebuild growth... Pfizer Inc. (NYSE:PFE) and Abbott Laboratories (NYSE:ABT) offer investors two very different dividend stories. Pfizer (NYSE:PFE) is working to rebuild growth before major patent expirations arrive, w… [+5139 chars]

    Source ↗
  • News8/24/2026neutral

    Pfizer vs. Johnson & Johnson: Which Pharma Giant Is Better Prepared for Its Patent Cliff? Patent expirations are forcing Pfizer Inc. (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ) to prove that their newer medicines can replace some of their most suc... Patent expirations are forcing Pfizer Inc. (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ) to prove that their newer medicines can replace some of their most successful franchises. Pfizer is simultan… [+5112 chars]

    Source ↗
  • News8/23/2026neutral

    Pfizer’s Turnaround is Gaining Traction, but Can New Products Offset its Patent Cliff? Pfizer Inc. (NYSE:PFE) is beginning to show signs of steadier growth following the sharp decline in its pandemic-related business. The pharmaceutical giant r... Pfizer Inc. (NYSE:PFE) is beginning to show signs of steadier growth following the sharp decline in its pandemic-related business. The pharmaceutical giant reported a 1% year-over-year operational in… [+4819 chars]

    Source ↗
  • News8/23/2026neutral

    Pfizer vs. Gilead: Which Drugmaker Has the Stronger Growth Story? The next few years will test whether Pfizer Inc. (NYSE:PFE) can replace yesterday’s blockbusters, and whether Gilead Sciences, Inc. (NASDAQ:GILD) can become... The next few years will test whether Pfizer Inc. (NYSE:PFE) can replace yesterday's blockbusters, and whether Gilead Sciences, Inc. (NASDAQ:GILD) can become more than an HIV company. Pfizer's (NYSE:P… [+5609 chars]

    Source ↗
  • News8/11/2026neutral

    Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era? Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX), two companies forever linked by their historic COVID-19 vaccine partnership, reported Q2 2026 earnings... Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX), two companies forever linked by their historic COVID-19 vaccine partnership, reported Q2 2026 earnings alongside major strategic announcements. W… [+6965 chars]

    Source ↗
  • News7/5/2026positive

    Pfizer Inc. (PFE): A Top Dividend Stock to Buy According to Hedge Funds amid Ibrance FDA Milestone Pfizer Inc. (NYSE:PFE) is one of the best dividend stocks to buy, according to hedge funds. On June 24, the US Food and Drug Administration approved the use... Pfizer Inc. (NYSE:PFE) is one of the best dividend stocks to buy, according to hedge funds. On June 24, the US Food and Drug Administration approved the use of Pfizer Inc. (NYSE:PFE)'s Ibrance in com… [+1605 chars]

    Source ↗
  • News6/24/2026neutral

    Pfizer (PFE) Reaffirms FY 2026 Outlook Amid Leadership Change With an annual dividend yield of 6.96%, Pfizer Inc. (NYSE:PFE) is included among the 12 Best S&P 500 Stocks to Buy for Dividends. Pfizer Inc. (NYSE:PFE) disc... With an annual dividend yield of 6.96%, Pfizer Inc. (NYSE:PFE) is included among the 12 Best S&P 500 Stocks to Buy for Dividends. Pfizer (PFE) Reaffirms FY 2026 Outlook Amid Leadership Change P… [+1709 chars]

    Source ↗
  • News6/13/2026positive

    Pfizer (PFE): The Best Longevity Stock to Buy Now Pfizer Inc. (NYSE:PFE) is one of the 7 Best Longevity Stocks to Buy Now. On June 8, 2026, Pfizer Inc. (NYSE:PFE) announced that the U.S. FDA approved an... Pfizer Inc. (NYSE:PFE) is one of the 7 Best Longevity Stocks to Buy Now. On June 8, 2026, Pfizer Inc. (NYSE:PFE) announced that the U.S. FDA approved an expanded indication for Hympavzi to include … [+1876 chars]

    Source ↗
  • News5/27/2026neutral

    BofA Raises Price Target on Pfizer (PFE) Following Strong Q1 Results Pfizer Inc. (NYSE:PFE) ranks among the best retirement stocks to buy now. On May 5, BofA Securities boosted its price objective for Pfizer Inc. (NYSE:PFE) to... Pfizer Inc. (NYSE:PFE) ranks among the best retirement stocks to buy now. On May 5, BofA Securities boosted its price objective for Pfizer Inc. (NYSE:PFE) to $27 from $26, retaining a Neutral rating … [+1753 chars]

    Source ↗
  • News5/26/2026neutral

    Is Pfizer Inc. (PFE) One of the Best Medical Stocks to Invest in According to Billionaires? Pfizer Inc. (NYSE:PFE) is one of the best medical stocks to invest in according to billionaires. Pfizer Inc. (NYSE:PFE) announced on May 20 data from its... Pfizer Inc. (NYSE:PFE) is one of the best medical stocks to invest in according to billionaires. Pfizer Inc. (NYSE:PFE) announced on May 20 data from its Phase 2 study evaluating the safety, tolerabi… [+1936 chars]

    Source ↗

Disclosed trades

No disclosed trades for $PFE.